Patent details

300644 Product Name: Teriflunomide, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300644
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1381356
Status:
SPC in force
Application number:
300644
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/13/838/001-005
Marketing Authorization Type:
EEA
Marketing Authorization Date:
26/08/2013
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
10/02/2014
First Marketing Authorization date:
26/08/2013
Grant date:
24/09/2014
Activation date:
04/04/2022
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
10/02/2014
SPC/SPC Extension Expiration Date:
03/04/2027
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
07/05/2019
 
 

 

Name:
Sanofi-aventis Deutschland GmbH
Address:
Brüningstrasse 50, 65929, FRANKFURT AM MAIN, France (FR)

Historical Applicant/holder

From:
26/08/2016
To:
07/05/2019

 

Name:
Aventisub LLC
Address:
3711 Kennett Pike, Suite 200, 19807, GREENVILLE, Delaware, United States of America (US)

From:
10/02/2014
To:
26/08/2016

 

Name:
Aventis Pharmaceuticals Inc.
Address:
55 Corporate Drive, 08807, Bridgewater, New Jersey, United States of America (US)

Agent

Name:
ir. A. Blokland c.s.
From:
10/02/2014
Address:
Algemeen Octrooi- en Merkenbureau B.V. Postbus 645, 5600 AP, Eindhoven, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
14/22
Publication date:
06/04/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
CO
Journal edition number:
25/19
Publication date:
19/06/2019
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
CO
Journal edition number:
41/16
Publication date:
12/10/2016
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
SPC
Journal edition number:
2014/40
Publication date:
01/10/2014
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

5

Bulletin Heading:
SPC
Journal edition number:
2014/10
Publication date:
05/03/2014
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201900867A
Date Registered:
07/05/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Sanofi-aventis Deutschland GmbH
Address:
Brüningstrasse 50, 65929, FRANKFURT AM MAIN, France (FR)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Merge
Deed Number:
RC201602162A
Date Registered:
26/08/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Aventisub LLC
Address:
3711 Kennett Pike, Suite 200, 19807, GREENVILLE, Delaware, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
17/03/2026
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
2400 Euro
Payer:
Arnold & Siedsma BV
Filing date Document type Document Description Number of pages File Type
18/09/2014 Outgoing Correspondence Outgoing Letter 1 PDF /4/4/6/0/0/0400300644/docs/300644_1_outgoingcorrespondence20140918.pdf
18/09/2014 SPC Documents Certificate SPC 1 PDF /4/4/6/0/0/0400300644/docs/300644_5_supplprotectioncertificate20201008042246891.pdf
06/06/2014 SPC Documents Annex SPC 3 PDF /4/4/6/0/0/0400300644/docs/300644_3_supplprotectioncertificate20201008042142434.pdf
06/06/2014 SPC Documents Accompanying letter SPC 2 PDF /4/4/6/0/0/0400300644/docs/300644_4_supplprotectioncertificate20201008042011771.pdf
06/06/2014 SPC Documents Annex SPC 1 PDF /4/4/6/0/0/0400300644/docs/300644_7_supplprotectioncertificate20201008042142378.pdf
11/03/2014 Outgoing Correspondence Outgoing Letter 1 PDF /4/4/6/0/0/0400300644/docs/300644_10_outgoingcorrespondence20140311.pdf
24/02/2014 Outgoing Correspondence Outgoing Letter 1 PDF /4/4/6/0/0/0400300644/docs/300644_8_outgoingcorrespondence20140224.pdf
10/02/2014 SPC Documents Accompanying letter SPC 1 PDF /4/4/6/0/0/0400300644/docs/300644_0_supplprotectioncertificate20201008041628054.pdf
10/02/2014 SPC Documents Marketing Authorization SPC 3 PDF /4/4/6/0/0/0400300644/docs/300644_2_supplprotectioncertificate20201008041203979.pdf
10/02/2014 SPC Documents Summary of the characteristics of the product 1 PDF /4/4/6/0/0/0400300644/docs/300644_6_supplprotectioncertificate20201008041728933.pdf
10/02/2014 Application Form First filed application form 3 PDF /4/4/6/0/0/0400300644/docs/300644_9_applicationform20140212.pdf